What a clinician may review
The exact assessment depends on your diagnosis and prescription pathway. These topics can help you prepare for a clinician or pharmacist conversation.
- Recent glucose or A1C information
- Kidney and cardiovascular history
- Current diabetes medications
Medication options to review
These options are shown for education and comparison. Seeing an option does not mean it is appropriate for you.
Dapagliflozin
Generic for Farxiga®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Empagliflozin
Generic for Jardiance®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Glimepiride
Generic for Amaryl®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Glipizide
Generic for Glucotrol®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Metformin
Generic for Glucophage®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Metformin ER
Diabetes care
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Mounjaro
Active ingredient: Tirzepatide
A prescription GIP/GLP-1 medication with FDA-approved uses for certain adults with type 2 diabetes. A clinician determines whether it is appropriate.
Ozempic
Active ingredient: Semaglutide
A prescription GLP-1 medication with FDA-approved uses for certain adults with type 2 diabetes. A clinician determines whether it is appropriate.
Pioglitazone
Generic for Actos®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
Sitagliptin
Generic for Januvia®
A generic prescription option commonly used for type 2 diabetes. A clinician determines whether it is appropriate.
When online care may not be enough
Urgent symptoms, an unsupported history, missing required measurements, or a clinician's judgment may require live or in-person care. PoeRx stops the commercial flow when a protocol identifies an urgent concern.